These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31682182)

  • 21. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2018 Jun; 34(5):373. PubMed ID: 29742011
    [No Abstract]   [Full Text] [Related]  

  • 22. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):557-8. PubMed ID: 23167518
    [No Abstract]   [Full Text] [Related]  

  • 23. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2015 Mar; 31(2):61-2. PubMed ID: 25715098
    [No Abstract]   [Full Text] [Related]  

  • 24. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2013 Jun; 29(5):449. PubMed ID: 23725200
    [No Abstract]   [Full Text] [Related]  

  • 25. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2015 Oct; 31(8):445-6. PubMed ID: 26367793
    [No Abstract]   [Full Text] [Related]  

  • 26. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2013; 29(6):513-4. PubMed ID: 23841863
    [No Abstract]   [Full Text] [Related]  

  • 27. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):785. PubMed ID: 24175582
    [No Abstract]   [Full Text] [Related]  

  • 28. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2014 Oct; 30(8):603-4. PubMed ID: 25280174
    [No Abstract]   [Full Text] [Related]  

  • 29. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2021 Oct; 37(8):439-440. PubMed ID: 34448621
    [No Abstract]   [Full Text] [Related]  

  • 30. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2020; 36(1):1-2. PubMed ID: 31971895
    [No Abstract]   [Full Text] [Related]  

  • 31. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2015 Apr; 31(3):130. PubMed ID: 25867880
    [No Abstract]   [Full Text] [Related]  

  • 32. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2015 Sep; 31(7):363-4. PubMed ID: 26262823
    [No Abstract]   [Full Text] [Related]  

  • 33. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2016 Nov; 32(9):563-564. PubMed ID: 27754810
    [No Abstract]   [Full Text] [Related]  

  • 34. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2014 Feb; 30(1):2-3. PubMed ID: 24450333
    [No Abstract]   [Full Text] [Related]  

  • 35. The accelerated drug approval.
    Novack GD
    Ocul Surf; 2010 Oct; 8(4):205-7. PubMed ID: 20964983
    [No Abstract]   [Full Text] [Related]  

  • 36. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2014 Aug; 30(6):445-6. PubMed ID: 24978906
    [No Abstract]   [Full Text] [Related]  

  • 37. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2015; 31(6):311-3. PubMed ID: 26076427
    [No Abstract]   [Full Text] [Related]  

  • 38. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2021 Nov; 37(9):493-494. PubMed ID: 34558971
    [No Abstract]   [Full Text] [Related]  

  • 39. Eyes on New Product Development: Regulations, Generics, and Disruptive Technologies.
    Novack GD
    J Ocul Pharmacol Ther; 2021 May; 37(4):191-192. PubMed ID: 33761283
    [No Abstract]   [Full Text] [Related]  

  • 40. On-Label and Off-Label Clinical Studies of FDA-Approved Ophthalmic Therapeutics.
    Gopal AD; Wallach JD; Shah SA; Regillo C; Ross JS
    Ophthalmology; 2021 Feb; 128(2):332-334. PubMed ID: 32682839
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.